PXMD (PXMD) Stock Price & Analysis
PXMD (PXMD) rose 0.00% to USD 0 as of July 25, 2026 at 03:05 UTC, according to Nexqual real-time market data.
PXMD last closed at USD 0; the session ranged USD 0–0 on volume of 300 shares. Market capitalization is $63,132, with a 52-week range of USD 0–0.02 (PNK). Source: Nexqual, July 25, 2026 at 03:05 UTC.
Key Statistics (as of July 25, 2026 at 03:05 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.02 |
| Volume | 300 shares |
| Market Cap | $63,132 |
| Exchange | PNK |
Technical Analysis (PXMD)
Nexqual's technical model rates PXMD "NEUTRAL" based on 3 bullish and 2 bearish signals across 124 daily candles, as of July 25, 2026 at 03:05 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 45.81 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (PXMD)
Wall Street analysts rate PXMD "None", per Nexqual as of July 25, 2026 at 03:05 UTC.
| Consensus Rating | None |
|---|
Earnings (PXMD)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2024-03-31 | USD -0.5 vs est -0.43 ▼ miss |
Source: Nexqual, July 25, 2026 at 03:05 UTC.
Financials & Fundamentals (PXMD)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.36 |
| Total Cash | $444,855 |
| Total Debt | $0 |
| Free Cash Flow | $-3.02M |
Source: Nexqual, July 25, 2026 at 03:05 UTC.
Financial Health Score (PXMD)
Nexqual rates PXMD's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 03:05 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $445K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$8M |
| Efficiency | Mixed — No data |
Ownership (PXMD)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.15% |
| Shares Outstanding | 126.26M |
| Short % of Float | +8.62% |
Source: Nexqual, July 25, 2026 at 03:05 UTC.
Leadership (PXMD)
PXMD is led by Howard J. Weisman (age 66), Chief Executive Officer, per Nexqual as of July 25, 2026 at 03:05 UTC.
| Chief Executive Officer | Howard J. Weisman (age 66) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ILAG | Intelligent Living Application | USD 3.45 | ▼ 0.23% |
| CDIO | Cardio Diagnostics Holdings Inc | USD 1.55 | ▼ 7.74% |
| SPRC | SciSparc Ltd. | USD 5.33 | ▲ 10.12% |
| HSCS | HeartSciences Inc. | USD 2.39 | ▼ 4.4% |
| HPCO | Hempacco Co., Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:05 UTC. This page is informational and not investment advice.